UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drug discovery today, ISSN 1359-6446, 02/2012, Volume 17, Issue 3-4, pp. 160 - 166
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Doxorubicin - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Drug Approval | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Drug Design | Liposomes | Neoplasms - pathology | Doxorubicin - adverse effects | Doxorubicin - administration & dosage | Drugs | Anthracyclines | Drug delivery systems | Care and treatment | Health aspects | Vehicles | Cancer | Index Medicus
Journal Article
Anti-cancer drugs, ISSN 0959-4973, 02/2014, Volume 25, Issue 2, pp. 140 - 149
cancer | histone deacetylase | solid tumors | histone deacetylase inhibitors | Pharmacology & Pharmacy | Oncology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Animals | Humans | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Histone Deacetylase Inhibitors - therapeutic use | Neoplasms - drug therapy | Index Medicus
Journal Article
European journal of human genetics : EJHG, ISSN 1018-4813, 10/2018, Volume 26, Issue 10, pp. 1399 - 1400
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 05/2018, Volume 103, Issue 5, pp. 770 - 777
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Tamoxifen - metabolism | Cytochrome P-450 CYP2D6 - genetics | Cytochrome P-450 CYP2D6 Inhibitors - therapeutic use | Humans | Genotype | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Pharmacogenetics - legislation & jurisprudence | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Tamoxifen - analogs & derivatives | Female | Neoplasm Recurrence, Local - genetics | Index Medicus | Abridged Index Medicus
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 09/2011, Volume 16, Issue 9, pp. 1239 - 1249
Monoclonal antibodies | KRAS | EGFR inhibitors | Concordance | Colorectal cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Proto-Oncogene Proteins - metabolism | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Colorectal Neoplasms - enzymology | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | ras Proteins - metabolism | Proto-Oncogene Proteins - genetics | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Animals | Colorectal Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Mutation | Colorectal Neoplasms - pathology | Index Medicus | Gastrointestinal Cancer
Journal Article
Nature (London), ISSN 0028-0836, 2014, Volume 506, Issue 7488, pp. 376 - +
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Humans | Asian Continental Ancestry Group - genetics | Computational Biology | Male | Drug Repositioning | Molecular Targeted Therapy | Drug Discovery | Case-Control Studies | Arthritis, Rheumatoid - pathology | Mice, Knockout | Arthritis, Rheumatoid - metabolism | Arthritis, Rheumatoid - genetics | Animals | Arthritis, Rheumatoid - drug therapy | Alleles | Polymorphism, Single Nucleotide - genetics | Female | Hematologic Neoplasms - genetics | Mice | Hematologic Neoplasms - metabolism | Quantitative trait loci | Genome-wide association studies | Rheumatoid arthritis | Genetic research | Genetic aspects | Research | Human genetics | Disease | Hematology | Cytokines | Genes | Genomics | Genomes | Meta-analysis | Proteins | Confidence intervals | Hypotheses | Quality control | Epigenetics | Population | Genetics | Health risk assessment | Asians | Cancer | Index Medicus | Life Sciences | Medicin och hälsovetenskap
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 10/2017, Volume 73, Issue 10, pp. 1247 - 1252
Pharmacogenetics | Biomedicine | Clinical pharmacology | Medical education | Cultural diversity | Pharmacology/Toxicology | Pharmacogenomics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Health Personnel - education | Pharmacogenetics - education | Education, Medical - organization & administration | Europe | Humans | Pharmacogenomic Variants | Surveys and Questionnaires | Pharmacogenomic Testing | Pharmacology, Clinical - education | Medical personnel | Surveys | Training | Health care | Drugs | Education | Drug metabolism | Pharmacology | Metabolism | Index Medicus
Journal Article
Biomedical chromatography, ISSN 0269-3879, 01/2020, Volume 34, Issue 1, pp. e4732 - n/a
Fluoropyrimidines | capecitabine | mass spectrometry | bioanalysis | chromatography | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Pharmacology & Pharmacy | Chemistry, Analytical | Science & Technology | Capecitabine - analysis | Animals | Chemical Fractionation | Capecitabine - isolation & purification | Humans | Mass Spectrometry | Chromatography, Liquid | Mice | Capecitabine - chemistry | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 12/2017, Volume 179, Issue 5, pp. 772 - 780
toxicity | paediatrics | pharmacokinetics | treosulfan | conditioning regimen | Life Sciences & Biomedicine | Hematology | Science & Technology | Busulfan - analogs & derivatives | Prospective Studies | Humans | Child, Preschool | Infant | Male | Antineoplastic Agents, Alkylating - administration & dosage | Busulfan - administration & dosage | Hematopoietic Stem Cell Transplantation - adverse effects | Antineoplastic Agents, Alkylating - blood | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Child | Graft vs Host Disease - etiology | Chemical and Drug Induced Liver Injury - etiology | Busulfan - blood | Drug Eruptions - etiology | Busulfan - adverse effects | Graft Survival | Transplantation Chimera | Mucositis - chemically induced | Hematologic Diseases - therapy | Hematologic Diseases - blood | Hematopoietic Stem Cell Transplantation - methods | Antineoplastic Agents, Alkylating - adverse effects | Medicine, Experimental | Pediatrics | Medical research | Transplantation | Hematopoietic stem cells | Stem cells | Graft-versus-host reaction | Toxicity | Variability | Mucosa | Medical treatment | Stem cell transplantation | Infants | Pharmacology | Exposure | Treosulfan | Patients | Clinical outcomes | Confidence intervals | Skin | Chimerism | Children | Pharmacokinetics | Index Medicus
Journal Article